No results for ‘’
Syncom Formulations (India) Ltd
₹13.12
(0.85%)
Wed, 05 Aug 2026, 05:10 am
Health Technology
Pharmaceuticals: Major
24.5KSyncom Formulations (India) Share Price Live Chart
1 Day
(0.85%)
No Result Found
Summary
Market Cap (in Cr)
1412.82
Net Profit (in Cr)
49.43
P/B
4.52
Sector P/E
33.76
P/E
31.04
EV/EBITDA
21.60
Debt/Equity (Industry)
0.24
Interest Cover (Industry)
9.79
ROCE (Industry)
14.04
RONW (Industry)
13.17
ROE
15.68
ROCE
18.54
Debt/Equity
0.12
EPS (TTM)
0.81
Dividend Yield
0
Book Value
4.41
Interest Cover
63.39
Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 50.57 | 50.57 | 50.57 | 50.57 | 50.57 |
| FII | 0.21 | 0.26 | 0.10 | 0.41 | 0.11 |
| DII | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public | 49.21 | 49.17 | 49.33 | 49.02 | 49.32 |
| Government | 0.00 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 17.54 | 15.55 | 14.34 | 13.56 | 12.35 | 11.57 | 9.58 |
| Fibonacci | 15.55 | 14.79 | 14.32 | 13.56 | 12.80 | 12.33 | 11.57 |
| Camarilla | 13.67 | 13.48 | 13.30 | 13.56 | 12.94 | 12.76 | 12.57 |
Pivots Level: Classic
R3
+3.98
17.54
R2
+1.99
15.55
R1
+0.77
14.34
S1
-1.22
12.35
S2
-1.99
11.57
S3
-3.98
9.58
Moving Average
Period
Value
10-EMA
13.27
20-EMA
13.42
30-EMA
13.55
50-EMA
13.68
100-EMA
13.80
200-EMA
14.35
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 22 May 2026 | board-meetings | Accounts, Quarterly Results | |
| 12 Feb 2026 | board-meetings | Quarterly Results | |
| 11 Aug 2025 | agm | ||
| 19 Sept 2024 | agm | ||
| 23 Aug 2024 | agm | Annual General Meeting | 24 Sept 2024 |
| 18 Aug 2023 | agm | Annual General Meeting | 20 Sept 2023 |
| 14 Aug 2023 | agm | ||
| 13 Aug 2022 | dividend | ₹0.03 Dividend /Share | 13 Sept 2022 |
| 13 Aug 2022 | agm | ||
| 27 Aug 2021 | agm |
Peer Comparison
Syncom Formulations (India) Ltd
Torrent Pharmaceuticals Ltd
Sun Pharmaceutical Industries Ltd
Dr Reddys Laboratories Ltd
Divis Laboratories Ltd
Cipla Ltd
Syncom Formulations (India) Ltd About
Syncom Formulations (India) is a renowned name in the Indian Pharmaceutical Industry represents synergistic combination of commitment and consistency. Currently Syncom manufactures and markets more than 200 pharmaceutical formulations products in various dosage forms like Tablets, Capsules, Liquids Orals, Liquid Vials and Ampoule Injections & Dry Vial injections, Dry Syrups, Ointments and Inhalers.
Industry
Pharmaceuticals - Indian - Bulk Drugs & Formln
Founded
1988
Headquarters
CEO
ANKIT KEDARMAL BANKDA
Employees
Contact
Website
http://www.syncomformulations.com
finance@sfil.in; sfil87@syncomformulations.com
Phone
91-22-30887744
Location
7 Niraj Indl Estate Andheri(E), Off Mahakali Caves Rd, Mumbai, Maharashtra, 400093
Syncom Formulations (India) Ltd Company History
| Year | History |
|---|---|
| 2011 |
|
| 2012 |
|
| 2013 |
|
| 2014 |
|
| 2022 |
|
Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| HRTI PRIVATE LIMITED | bulk | Sell | 8150466 | 25.14 | 09 Sept 2024 |
| HRTI PRIVATE LIMITED | bulk | Buy | 8536197 | 25.26 | 09 Sept 2024 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 7106640 | 24.91 | 09 Sept 2024 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 7106640 | 24.86 | 09 Sept 2024 |
| HRTI PRIVATE LIMITED | bulk | Buy | 4707047 | 23.37 | 06 Sept 2024 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 5329278 | 23.42 | 06 Sept 2024 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 5329278 | 23.46 | 06 Sept 2024 |
| HRTI PRIVATE LIMITED | bulk | Sell | 5094857 | 23.4 | 06 Sept 2024 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 5331418 | 20.79 | 26 Aug 2024 |
| HRTI PRIVATE LIMITED | bulk | Buy | 7590091 | 20.78 | 26 Aug 2024 |
Frequently Asked Questions
1.What is the stock price of Syncom Formulations (India) Ltd?
As of 05/08/2026 at 10:40 AM, Syncom Formulations (India) Ltd shares are trading at ₹13.12.
2.What is the market cap. of Syncom Formulations (India) Ltd?
As of 05/08/2026, the market capitalization of Syncom Formulations (India) Ltd is ₹1,235.16 crore.
3.When was Syncom Formulations (India) Ltd founded?
Syncom Formulations (India) Ltd was founded in 1988.
4.What are the P/E and P/B ratios of Syncom Formulations (India) Ltd?
As of 05/08/2026, Syncom Formulations (India) Ltd has a P/E ratio of 16.09 and a P/B ratio of 4.52.
5.How can I buy shares of Syncom Formulations (India) Ltd?
You can buy shares of Syncom Formulations (India) Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.
6.What is the shareholding pattern of Syncom Formulations (India) Ltd?
As of March,2026, promoters hold 50.57% in Syncom Formulations (India) Ltd, while FIIs, DIIs and public shareholders hold 0.21%, 0.00% and 49.21%, respectively. The government holds 0.00%.
7.Does Syncom Formulations (India) Ltd pay dividends?
Yes, Syncom Formulations (India) Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹₹0.03 Dividend /Share per share.
8.What are the latest financial results of Syncom Formulations (India) Ltd?
For January,2024, Syncom Formulations (India) Ltd reported revenue of ₹457.00 crore and a net profit of ₹49.44 crore.
9.What is the Stock symbol of Syncom Formulations (India) Ltd?
SYNCOMF is the stock symbol of Syncom Formulations (India) Ltd.
10.Who is the CEO of Syncom Formulations (India) Ltd?
The CEO of Syncom Formulations (India) Ltd is ANKIT KEDARMAL BANKDA.